Picein

CAS No. 530-14-3

Picein( Ameliaroside | Salicinerein | Salinigrin | Piceoside )

Catalog No. M29334 CAS No. 530-14-3

Picein is derived from Picrorhiza kurroa and shows antioxidant properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 93 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Picein
  • Note
    Research use only, not for human use.
  • Brief Description
    Picein is derived from Picrorhiza kurroa and shows antioxidant properties.
  • Description
    Picein is derived from Picrorhiza kurroa and shows antioxidant properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Ameliaroside | Salicinerein | Salinigrin | Piceoside
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    Antioxidant
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    530-14-3
  • Formula Weight
    298.29
  • Molecular Formula
    C14H18O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)C2=CC=C(C(C)=O)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Isovitexin(b)

    Isovitexin an active component of many traditional Chinese medicines shows various activities such as anti-oxidant anti-inflammatory anti-alzheimer disease (AD) effects and so on.

  • O-Desmethylangolensi...

    O-Desmethylangolensin, an intestinal bacterial metabolite of soybean sapogenins, possesses anticancer and antioxidant activities, and inhibits the proliferation of human breast cancer MCF-7 cells by inducing apoptosis and promoting cell cycle arrest.

  • Nrf2 activator-3

    Nrf2 activator-3 is a potent Nrf2 activator with potential anti-inflammatory, antioxidant, and anti-tumor activities, suitable for studying neurological and immune-related diseases.